Deca-Max focuses on connective tissue support and recovery pathways, aligning with research emphasizing joint integrity and tissue resilience in strength training contexts
IQVIA notes six big shifts in medicines use in 2023: Growing use of immunology treatments up 60% from 2019 with treatment of Crohns disease and psoriasis up 26% and 15%, respectively Rising use of novel obesity drugs which is the GLP-1 story Ill relate to the next graphic, below
Don't click "I agree" without reading it
Without strong muscular tension, the constant micro-movements of daily life begin to wear directly on your ligaments and joints rather than being absorbed by your muscles
Glycemic control: The GLP-1 component supports glucose-dependent insulin secretion and improved glycemic markers in studies of the approved molecule [2]
Sivasenthil Arumugam, MD 1,2